BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38653067)

  • 1. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.
    Gamal MA; Fahim SH; Giovannuzzi S; Fouad MA; Bonardi A; Gratteri P; Supuran CT; Hassan GS
    Eur J Med Chem; 2024 May; 271():116434. PubMed ID: 38653067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of the common functional groups in bioactive molecules: Exploring dual inhibitory potential and computational analysis of keto esters against α-glucosidase and carbonic anhydrase-II enzymes.
    Khan I; Khan A; Halim SA; Khan M; Zaib S; Al-Yahyaei BEM; Al-Harrasi A; Ibrar A
    Int J Biol Macromol; 2021 Jan; 167():233-244. PubMed ID: 33249154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs.
    Lolak N; Akocak S; Türkeş C; Taslimi P; Işık M; Beydemir Ş; Gülçin İ; Durgun M
    Bioorg Chem; 2020 Jul; 100():103897. PubMed ID: 32413628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors.
    Mahmood SU; Saeed A; Bua S; Nocentini A; Gratteri P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():381-386. PubMed ID: 29421714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity.
    Abdelhakeem MM; Morcoss MM; Hanna DA; Lamie PF
    Bioorg Chem; 2024 Mar; 144():107154. PubMed ID: 38309003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
    Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
    Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
    Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies.
    Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Berrino E; Abdelsamie AS; El Diwani HI; Supuran CT
    Bioorg Med Chem; 2020 Mar; 28(5):115329. PubMed ID: 32007388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors.
    Singh P; Purnachander Yadav P; Swain B; Thacker PS; Angeli A; Supuran CT; Arifuddin M
    Bioorg Chem; 2021 Mar; 108():104647. PubMed ID: 33530019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
    Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK
    Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII.
    George RF; Said MF; Bua S; Supuran CT
    Bioorg Chem; 2020 Jan; 95():103514. PubMed ID: 31887473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies.
    Elkamhawy A; Woo J; Nada H; Angeli A; Bedair TM; Supuran CT; Lee K
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiosemicarbazone-benzenesulfonamide Derivatives as Human Carbonic Anhydrases Inhibitors: Synthesis, Characterization, and
    Trawally M; Demir-Yazıcı K; Angeli A; Kaya K; Akdemir A; Supuran CT; Güzel-Akdemir Ö
    Anticancer Agents Med Chem; 2024; 24(9):649-667. PubMed ID: 38367264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal.
    Mishra CB; Kumari S; Angeli A; Bua S; Buonanno M; Monti SM; Tiwari M; Supuran CT
    Eur J Med Chem; 2018 Aug; 156():430-443. PubMed ID: 30015076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
    Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
    Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors.
    Le Darz A; Mingot A; Bouazza F; Castelli U; Karam O; Tanc M; Supuran CT; Thibaudeau S
    J Enzyme Inhib Med Chem; 2015; 30(5):737-45. PubMed ID: 25431145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.